REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD
RNS Number : 1620YSociete Generale SA17 August 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
16/08/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,609,962
0.21
6,009,541
0.77
(2) Cash-settled derivatives:
4,747,552
0.61
2,026
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
121,500
0.02
0
0.00
TOTAL:
6,479,014
0.83
6,011,567
0.77
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Purchase
100
4558
Ordinary
Purchase
100
4558
Ordinary
Purchase
600
4551
Ordinary
Purchase
400
4608
Ordinary
Purchase
100
4608
Ordinary
Purchase
200
4608
Ordinary
Purchase
200
4615
Ordinary
Purchase
100
4551
Ordinary
Purchase
200
4551
Ordinary
Purchase
600
4551
Ordinary
Purchase
300
4572
Ordinary
Purchase
1,600
4613
Ordinary
Purchase
2,500
4613
Ordinary
Purchase
100
4555
Ordinary
Purchase
200
4551.5
Ordinary
Purchase
300
4559.5
Ordinary
Purchase
100
4550
Ordinary
Purchase
200
4536
Ordinary
Purchase
200
4538
Ordinary
Purchase
100
4602
Ordinary
Purchase
300
4542
Ordinary
Purchase
200
4537.5
Ordinary
Purchase
500
4539
Ordinary
Purchase
300
4540
Ordinary
Purchase
200
4542
Ordinary
Purchase
300
4541
Ordinary
Purchase
100
4600
Ordinary
Purchase
100
4600
Ordinary
Purchase
100
4559
Ordinary
Purchase
100
4604
Ordinary
Purchase
200
4538
Ordinary
Purchase
500
4610
Ordinary
Purchase
100
4557
Ordinary
Purchase
200
4540
Ordinary
Purchase
300
4606
Ordinary
Purchase
400
4537
Ordinary
Purchase
600
4608
Ordinary
Purchase
700
4538
Ordinary
Purchase
500
4538
Ordinary
Purchase
800
4558
Ordinary
Purchase
600
4539
Ordinary
Purchase
500
4533
Ordinary
Purchase
100
4532
Ordinary
Purchase
1,000
4550
Ordinary
Purchase
700
4549
Ordinary
Purchase
300
4555
Ordinary
Purchase
500
4556
Ordinary
Purchase
1,000
4585
Ordinary
Purchase
600
4585
Ordinary
Purchase
500
4611
Ordinary
Purchase
100
4559
Ordinary
Purchase
1,000
4603
Ordinary
Purchase
1,000
4541
Ordinary
Purchase
200
4541
Ordinary
Purchase
1,000
4601
Ordinary
Purchase
100
4562
Ordinary
Purchase
100
4536
Ordinary
Purchase
100
4544
Ordinary
Purchase
200
4608
Ordinary
Purchase
200
4548
Ordinary
Purchase
400
4613
Ordinary
Purchase
300
4614
Ordinary
Purchase
100
4548
Ordinary
Purchase
1,000
4549
Ordinary
Purchase
500
4621
Ordinary
Purchase
1,000
4614
Ordinary
Purchase
1,000
4543
Ordinary
Purchase
400
4542
Ordinary
Purchase
1,000
4543
Ordinary
Purchase
800
4594
Ordinary
Purchase
1,300
4583
Ordinary
Purchase
700
4550
Ordinary
Purchase
500
4621
Ordinary
Purchase
100
4557
Ordinary
Purchase
800
4606
Ordinary
Purchase
200
4617
Ordinary
Purchase
1,000
4621
Ordinary
Purchase
1,000
4614
Ordinary
Purchase
500
4603
Ordinary
Purchase
100
4600
Ordinary
Purchase
600
4618
Ordinary
Purchase
100
4546
Ordinary
Purchase
400
4546
Ordinary
Purchase
300
4602
Ordinary
Purchase
1,000
4618
Ordinary
Purchase
700
4610
Ordinary
Purchase
1,000
4545
Ordinary
Purchase
300
4542
Ordinary
Purchase
700
4542
Ordinary
Purchase
300
4550
Ordinary
Purchase
700
4555
Ordinary
Purchase
1,000
4551
Ordinary
Purchase
1,000
4555
Ordinary
Purchase
700
4540
Ordinary
Purchase
500
4608
Ordinary
Purchase
200
4605
Ordinary
Purchase
700
4611
Ordinary
Purchase
600
4603
Ordinary
Purchase
500
4603
Ordinary
Purchase
100
4539
Ordinary
Purchase
100
4539
Ordinary
Purchase
100
4537
Ordinary
Purchase
100
4542
Ordinary
Purchase
200
4603
Ordinary
Purchase
500
4557
Ordinary
Purchase
200
4538
Ordinary
Purchase
900
4604
Ordinary
Purchase
800
4539
Ordinary
Purchase
200
4539
Ordinary
Purchase
300
4607
Ordinary
Purchase
700
4616
Ordinary
Purchase
400
4541
Ordinary
Purchase
100
4616
Ordinary
Purchase
1,000
4560
Ordinary
Purchase
100
4608
Ordinary
Purchase
1,000
4617
Ordinary
Purchase
1,000
4542
Ordinary
Purchase
600
4542
Ordinary
Purchase
100
4534
Ordinary
Purchase
1,000
4608
Ordinary
Purchase
600
4608
Ordinary
Purchase
300
4572
Ordinary
Purchase
700
4620
Ordinary
Purchase
900
4604
Ordinary
Purchase
900
4566
Ordinary
Purchase
100
4546
Ordinary
Purchase
1,000
4575
Ordinary
Purchase
100
4610
Ordinary
Purchase
100
4550.9
Ordinary
Purchase
300
4549
Ordinary
Purchase
1,600
4615
Ordinary
Purchase
700
4612
Ordinary
Purchase
100
4617
Ordinary
Purchase
1,000
4615
Ordinary
Purchase
300
4617
Ordinary
Purchase
1,500
4618
Ordinary
Purchase
100
4603
Ordinary
Purchase
12,100
4613
Ordinary
Purchase
12,900
4613
Ordinary
Purchase
25,800
4540
Ordinary
Purchase
239
4540
Ordinary
Purchase
80
4490
Ordinary
Sale
200
4581
Ordinary
Sale
200
4582
Ordinary
Sale
300
4582
Ordinary
Sale
200
4613
Ordinary
Sale
200
4607
Ordinary
Sale
300
4605
Ordinary
Sale
300
4606
Ordinary
Sale
300
4566
Ordinary
Sale
600
4556
Ordinary
Sale
500
4538
Ordinary
Sale
100
4533
Ordinary
Sale
300
4536.5
Ordinary
Sale
2,900
4613
Ordinary
Sale
100
4616.5
Ordinary
Sale
700
4617
Ordinary
Sale
700
4543
Ordinary
Sale
700
4551
Ordinary
Sale
1,500
4550
Ordinary
Sale
200
4618
Ordinary
Sale
200
4585
Ordinary
Sale
100
4618
Ordinary
Sale
200
4609
Ordinary
Sale
500
4584
Ordinary
Sale
100
4541
Ordinary
Sale
1,200
4543
Ordinary
Sale
100
4544
Ordinary
Sale
900
4541
Ordinary
Sale
700
4555
Ordinary
Sale
200
4544
Ordinary
Sale
900
4541
Ordinary
Sale
300
4540
Ordinary
Sale
700
4612
Ordinary
Sale
100
4542
Ordinary
Sale
1,300
4542
Ordinary
Sale
500
4546
Ordinary
Sale
200
4545
Ordinary
Sale
500
4544
Ordinary
Sale
300
4584
Ordinary
Sale
700
4543
Ordinary
Sale
500
4579
Ordinary
Sale
500
4603
Ordinary
Sale
300
4611
Ordinary
Sale
200
4581
Ordinary
Sale
1,300
4580
Ordinary
Sale
100
4581
Ordinary
Sale
800
4558
Ordinary
Sale
200
4579
Ordinary
Sale
1,200
4536
Ordinary
Sale
2,400
4564
Ordinary
Sale
1,500
4602
Ordinary
Sale
100
4603
Ordinary
Sale
200
4538
Ordinary
Sale
700
4615
Ordinary
Sale
1,200
4539
Ordinary
Sale
200
4616
Ordinary
Sale
200
4561
Ordinary
Sale
300
4616
Ordinary
Sale
300
4562
Ordinary
Sale
200
4563
Ordinary
Sale
1,200
4560
Ordinary
Sale
1,300
4539
Ordinary
Sale
700
4609
Ordinary
Sale
400
4615
Ordinary
Sale
100
4548
Ordinary
Sale
200
4550
Ordinary
Sale
300
4550
Ordinary
Sale
2,100
4618
Ordinary
Sale
100
4614
Ordinary
Sale
300
4616
Ordinary
Sale
100
4565
Ordinary
Sale
200
4608
Ordinary
Sale
300
4541
Ordinary
Sale
1,300
4620
Ordinary
Sale
400
4603
Ordinary
Sale
1,200
4542
Ordinary
Sale
100
4613
Ordinary
Sale
1,200
4541
Ordinary
Sale
1,100
4610
Ordinary
Sale
700
4563
Ordinary
Sale
400
4551
Ordinary
Sale
600
4601
Ordinary
Sale
300
4599
Ordinary
Sale
700
4560
Ordinary
Sale
200
4561
Ordinary
Sale
400
4564
Ordinary
Sale
100
4561
Ordinary
Sale
100
4565
Ordinary
Sale
400
4610
Ordinary
Sale
600
4543
Ordinary
Sale
1,600
4531
Ordinary
Sale
500
4531
Ordinary
Sale
400
4539
Ordinary
Sale
200
4601
Ordinary
Sale
1,000
4610
Ordinary
Sale
500
4602
Ordinary
Sale
100
4618
Ordinary
Sale
300
4616
Ordinary
Sale
1,000
4621
Ordinary
Sale
1,200
4551
Ordinary
Sale
400
4613
Ordinary
Sale
100
4549
Ordinary
Sale
100
4550
Ordinary
Sale
1,200
4549
Ordinary
Sale
600
4536
Ordinary
Sale
200
4539
Ordinary
Sale
1,600
4554
Ordinary
Sale
200
4599
Ordinary
Sale
500
4618
Ordinary
Sale
600
4549
Ordinary
Sale
1,200
4609
Ordinary
Sale
600
4546
Ordinary
Sale
500
4601
Ordinary
Sale
1,200
4540
Ordinary
Sale
100
4546
Ordinary
Sale
900
4612
Ordinary
Sale
200
4572
Ordinary
Sale
1,900
4608
Ordinary
Sale
800
4544
Ordinary
Sale
200
4605
Ordinary
Sale
1,200
4556
Ordinary
Sale
100
4571
Ordinary
Sale
300
4570
Ordinary
Sale
2,000
4608
Ordinary
Sale
100
4609
Ordinary
Sale
1,500
4607
Ordinary
Sale
800
4607
Ordinary
Sale
200
4604
Ordinary
Sale
200
4608
Ordinary
Sale
100
4551
Ordinary
Sale
300
4608
Ordinary
Sale
200
4549
Ordinary
Sale
1,200
4540
Ordinary
Sale
400
4562
Ordinary
Sale
1,200
4616
Ordinary
Sale
100
4563
Ordinary
Sale
1,300
4540
Ordinary
Sale
1,200
4616
Ordinary
Sale
1,300
4617
Ordinary
Sale
1,200
4540
Ordinary
Sale
500
4607
Ordinary
Sale
400
4539
Ordinary
Sale
1,200
4559
Ordinary
Sale
200
4538
Ordinary
Sale
900
4537
Ordinary
Sale
100
4537
Ordinary
Sale
600
4545
Ordinary
Sale
100
4544
Ordinary
Sale
700
4566
Ordinary
Sale
600
4617
Ordinary
Sale
900
4550
Ordinary
Sale
1,600
4611
Ordinary
Sale
300
4613
Ordinary
Sale
500
4540
Ordinary
Sale
15,000
4613
Ordinary
Sale
16,780
4588.3433
Ordinary
Sale
164
4587
Total Purchases
119,419
Total Sales
124,844
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
Ordinary
CFD
Increasing a long position
16,780
4588.3433
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
17/08/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
OTC put-option
Sale
15,700
4707
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,000
5075.10
European options
14/12/2018
Ordinary
OTC put-option
Sale
29,600
5073.65
European options
14/12/2018
Ordinary
OTC put-option
Sale
15,500
4491.40
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,700
4533.90
European options
14/12/2018
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETGGUUARUPRUBM
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement